Embolic Stroke clinical trials
The registry lists 40 studies for Embolic Stroke across more than 10 countries. 11 are recruiting or about to start. 24 of them are mainly about Embolic Stroke (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29.
Get an email when these change. Save the Embolic Stroke studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
University of Alberta (3) · Ischemia Care LLC (2) · Beijing Tiantan Hospital (2) · Haukeland University Hospital (2) · Xijing Hospital (2) · Moleac Pte Ltd. (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · University Hospital, Akershus (1)
What is being tested here
Drugs under test in Embolic Stroke studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Aug 2027Translational Immunodiagnostics in Stroke (TrImS) · The University of Hong Kong
Who these studies take
Of the 7 Embolic Stroke studies recruiting now, 5 (71%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (14%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 6 (86%) | 6 (86%) |
| 30 | 7 (100%) | 7 (100%) |
| 40 | 7 (100%) | 7 (100%) |
| 50 | 7 (100%) | 7 (100%) |
| 65 | 7 (100%) | 7 (100%) |
| 75 | 7 (100%) | 7 (100%) |
| 85 | 6 (86%) | 6 (86%) |
Across all 40 studies, recruiting or not: 5% stop at 75 or younger and 0% at 65; 8% take children; 0% are for women only and 0% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Results posted1
- Long-term Outcomes After Percutaneous Closure of PFOOct 29, 2026NCT05558774
Studies
Recruiting first, then most recently updated. Showing 40 of 40. search them.
- Transcranial Doppler Evaluation After Endovascular Thrombectomy for Acute Ischemic Stroke (PRECISE-TCD)Not yet recruitingNCT070133961 country
- Master Study Protocol for the Cohort of the Specialist Network Stroke (SN Stroke)(Stroke-CORE)Not yet recruitingNCT075536501 country
- Translational Immunodiagnostics in Stroke (TrImS)RecruitingNCT053009971 country
- Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown CauseRecruitingNCT07295769Not applicable1 country
- Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial FibrillationRecruitingNCT069546101 country
- Detecting Cardiac Thrombi in Acute Ischemic Stroke on Cardiac CT Versus Transoesophageal EchocardiographyRecruitingNCT065852281 country
- Cardiac Abnormalities in Stroke Prevention and Risk of RecurrenceEnrolling by invitationNCT063983661 country
- EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined SourceRecruitingNCT06715449Phase 2/31 country
- Biomarkers of Acute Stroke in ClinicRecruitingNCT038974781 country
- MLC1501 Study Assessing Efficacy in STROke RecoveryNot yet recruitingNCT05046106Phase 2/3
- Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic EventsRecruitingNCT045592431 country
- Long-term Outcomes After Percutaneous Closure of PFOCompletedNCT055587741 country
- Left Atrial Appendage Closure With SentreHeart Lariat® DeviceCompletedNCT02681042Not applicable1 country
- Diagnostic Yield of Cardiac CT to Detect Cardiac Thrombi in Acute Ischemic Stroke: an Individual Patient Data Meta-AnalysisCompletedNCT071650931 country
- MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor DeficitsCompletedNCT05289947Phase 22 countries
- Stroke of Unknown Cause in Women: The Impact of Long-term Heart Monitoring on Stroke RecurrenceActive, not recruitingNCT071948111 country
- Impaired Endothelial Integrity in Patients With Embolic Stroke of Undetermined Source (ESUS)Active, not recruitingNCT036094371 country
- Long-term Results of Percutaneous Left Atrial Closure at Brest University Hospital (CLAPOT)Active, not recruitingNCT062322781 country
- Lixiana Acute Stroke Evaluation RegistryCompletedNCT03494530Phase 41 country
- Post-Embolic Rhythm Detection With Implantable Versus External MonitoringCompletedNCT02428140Not applicable1 country
- Posterior Wall And Left Atrial Appendage Empiric Electrical Isolation for Non-Paroxysmal Atrial FibrillationTerminatedNCT04216667Not applicable7 countries
- Atrial Cardiomyopathy in Patients With Stroke of Undetected MechanismCompletedNCT038309831 country
- A Real-world Registry Study of Multidisciplinary Collaborative Diagnosis and Treatment Model for Cardioembolic StrokeStatus unknownNCT054989091 country
- Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic StrokeStatus unknownNCT054863512 countries
- Thirty Day Heart Monitoring for Detection of Atrial Fibrillation Among Cryptogenic Stroke PatientsCompletedNCT037128651 country
- Apixaban for Treatment of Embolic Stroke of Undetermined SourceCompletedNCT02427126Phase 31 country
- Norwegian Carotid Plaque StudyCompletedNCT027596531 country
- Relationship Between Renal Function and Pharmacokinetics of Apixaban and Clinical Outcome of Apixaban in Thai Non-valvular Atrial Fibrillation PatientsStatus unknownNCT046847321 country
- Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With EmbolismCompletedNCT03090113Phase 41 country
- Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)CompletedNCT020148961 country
- Current Situation of Natural History, Diagnosis and Treatment in Inpatients With Embolism Stroke of Unknown Cause (ESUS)CompletedNCT04455529
- Eliquis Acute Stroke Safety EvaluationCompletedNCT044354181 country
- Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial FibrillationCompletedNCT021813611 country
- Identification the Cause of Cerebral Infarction in Patients With CancerCompletedNCT022124961 country
- Norwegian Microemboli in Acute Stroke StudyStatus unknownNCT035433191 country
- Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY)Status unknownNCT027424801 country
- Perfusion Pressure Cerebral Infarction Trial (PPCI)CompletedNCT02185885Not applicable1 country
- The Diagnosis Value of Serum Marker in Stroke Associated With Nonvalvular Atrial Fibrillation.Status unknownNCT021813741 country
- Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted CoilingStatus unknownNCT02224131Phase 41 country
- Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in StrokeStatus unknownNCT02159287Phase 21 country